🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
ARQ 197 or placebo in combination with irinotecan and cetuximab in particip...
Status
Completed
Location
Multiple Locations
Start Date
2010-01-26
Trial ID
NCT01075048
Treatments Being Tested
This is a phase I study to determine the safety, tolerability and recommend...
Status
Completed
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT01069757
Treatments Being Tested
This study aims to assess the role of MET inhibitors as maintenance treatme...
Status
Terminated
Location
Istituto Oncologico Veneto
Start Date
2016-02-19
Trial ID
NCT02608411
Treatments Being Tested
To determine the safety, tolerability and recommended Phase 2 dose (RP2D) o...
Status
Completed
Location
Premiere Oncology
Start Date
2006-01
Trial ID
NCT00302172
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of ARQ...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01656265
Treatments Being Tested
This phase I trial studies the side effects and best dose of tivantinib in ...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2012-10
Trial ID
NCT01725191
Treatments Being Tested
To assess the PK and safety profiles of ARQ 197 in extensive and poor metab...
Status
Completed
Location
Covance Clinical Research Unit, Inc.
Start Date
2008-03
Trial ID
NCT00651638
Treatments Being Tested
This phase I trial studies the side effects of and best dose of tivantinib ...
Status
Completed
Location
Penn State Milton S Hershey Medical Center
Start Date
2012-12-06
Trial ID
NCT01749384
Treatments Being Tested
This randomized phase II trial studies how well tivantinib with or without ...
Status
Completed
Location
University of Arizona Cancer Center-Orange Grove Campus
Start Date
2012-08-20
Trial ID
NCT01688973
Treatments Being Tested
This is a bioequivalence study designed to compare three solid states of AR...
Status
Completed
Location
Covance Clinical Research Unit, Inc.
Start Date
2008-04
Trial ID
NCT00658554
Treatments Being Tested